Monday, August 20, 2018
Company News: Page (1) of 1 - 02/06/18 Email this story to a friend. email article Print this page (Article printing at page facebook
MVC Eye Care Welcomes Dr. Lisa Holtman to its Team of Specialists
(February 06, 2018)
MVC Eye Care Welcomes Dr. Lisa Holtman to its Team of Specialists

MVC Eye Care recently welcomed Dr. Lisa Holtman, O.D., as a resident, in association with the Southern College of Optometry in Memphis, TN. “Lisa has a great passion for helping people, and a particular interest in working with children who are struggling in school," said Dr. Kevin Chauvette, O.D., F.C.O.V.D., owner of MVC Eye Care.

Dr. Holtman, who graduated Magna Cum Laude from Bemidji State University with a Bachelor of Science in Mathematics and recently earned her Doctor of Optometry from Midwestern University Arizona College of Optometry, has a specialty in pediatrics vision therapy and neurorehabilitation. Dr. Holtman and Dr. Chauvette both provide specialty care for patients recovering from brain injury and stroke, and travel to see patients at five different outpatient rehab hospitals.

“We see patients who have recently recovered from a stroke, brain surgery, or trauma, and all those problems can have a devastating effect on vision," noted Dr. Chauvette. “We provide solutions to this, whether through optical means or vision therapy."

In addition to Dr. Holtman joining the team, MVC Eye Care, which has branches in Manchester, Merrimack, Milford and Windham, is celebrating twenty years of donating glasses to the needy.

“We have drop-off areas in all of our four offices and the donated glasses are given to people who cannot afford them through the Lion's Club and Christian Missions," concluded Dr. Chauvette.

About Dr. Kevin Chauvette, MVC Eye Care
Dr. Kevin Chauvette specializes in pediatric vision care, vision care for children struggling in school, children with developmental disabilities (autism, cerebral palsy, etc.), with a concentration in the area of neuro-rehabilitation. MVC Eye Care services include eye exams and vision tests, eye disease management, pre-op and post-op care for LASIK patients, and eyeglasses and contact lenses in Manchester. For more information, call the Manchester office at (603) 644-6100, the Merrimack office at (603) 424-0404, the Milford office at (603) 672-0338, or the Windham office at (603) 792-2020, or visit

About the NALA™
The NALA offers small and medium-sized businesses effective ways to reach customers through new media. As a single-agency source, the NALA helps businesses flourish in their local community. The NALA's mission is to promote a business' relevant and newsworthy events and achievements, both online and through traditional media. The information and content in this article are not in conjunction with the views of the NALA. For media inquiries, please call 805.650.6121, ext. 361.

Read the full story at

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The global connected health device market is expected to reach an estimated $36.1 billion by 2023 and is forecast to grow at a CAGR of 21.1% from 2018 to 2023
  • Global Hemodialysis and Peritoneal Dialysis Market to Witness a CAGR of 5.9% during 2018-2024
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023

  • Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
  • /R E P E A T -- Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution/
  • Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines